Raynard Kington became the acting director of the National Institutes of Health, following the departure of Elias Zerhouni, as of Oct. 31. Kington has taken over the post until President-elect Barack Obama appoints a new director. He has served as Zerhouni’s deputy since 2003. Prior to that, he was associate director of NIH for behavioral and social sciences research.
Jonathan Sheridan is the new president and CEO at Integrated Genomics, a bioinformatics products and services provider that specializes in microbial genomics. He takes over from John Elling who will remain chairman of the board.
Prior to Integrated Genomics, Sheridan was VP of commercial operations at HTG, where he was responsible for forming new business partnerships with pharmaceutical and life sciences companies, establishing research agreements with academic institutions, and managing the global commercial sales and marketing teams.
Sheridan also held senior positions with PerkinElmer Life and Analytical Sciences, Epicentre Biotechnologies, Genomica, Lion Biosciences, PerkinElmer Cetus, Beckman Coulter, and Monsanto.